TREACE JOHN T. (Chief Executive Officer) purchased 0.4% of their position (21.49K shares) of TREACE MEDICAL CONCEPTS, INC. on the open market
Open‑market purchase worth $450.3K — a small addition. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 8/29/2022ACC: 0001209191-22-047786
DirectorOfficer10% Owner· Chief Executive Officer
Since Apr 2021
+21.49K
Net shares
Net buyer
$450.3K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
21.49K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+21.49K
Price / share
$20.95
Trade value
$450.34K
% of position
0.4%
8/26/2022
5.48M→5.51M
Total
Net shares
+21.49K
Net value
$450.34K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/26/2022 | P · Purchase | +21.49K | $20.95 | $450.34K | 0.4% | 5.48M | 5.51M |
| Total | +21.49K | $450.34K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)4
Common Stock
IndirectShares owned408.82K
Common Stock
IndirectShares owned1.47M
Common Stock
IndirectShares owned1.84M
Common Stock
IndirectShares owned1.60M
Total
5.32M indirect5.32M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 408.82K | Indirect |
| Common Stock | 1.47M | Indirect |
| Common Stock | 1.84M | Indirect |
| Common Stock | 1.60M | Indirect |
| Total | 5.32M | 5.32M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported